January 27, 2025 - 20:52

SGMC Health is raising the bar in cardiac care with the introduction of a cutting-edge Cardiac Electrophysiology (EP) Lab at its main campus. This new facility is designed to enhance the diagnosis and treatment of heart rhythm disorders, providing patients with access to the latest technology and specialized care.
In addition to the EP Lab, SGMC Health has also implemented significant upgrades to its existing Cath Lab. These improvements are aimed at optimizing procedures and ensuring that patients receive the highest quality of care possible. With state-of-the-art equipment and a team of highly skilled professionals, the upgraded facilities will facilitate a range of cardiac interventions, from diagnostic tests to complex procedures.
The launch of these advanced cardiac care options reflects SGMC Health's commitment to improving patient outcomes and providing comprehensive heart care services. As heart disease remains a leading health concern, these enhancements are expected to play a crucial role in the community's overall health and well-being.
July 2, 2026 - 04:03
VA health secretary quits less than a year into tenureJohn Bartrum, the official who oversaw the Veterans Health Administration`s troubled rollout of a new electronic health records system, has resigned from his post less than a year after taking the...
July 1, 2026 - 08:37
Anglia Ruskin mental health nursing course under reviewThe Nursing and Midwifery Council has called for an `extraordinary review` of the mental health nursing course at Anglia Ruskin University. The regulatory body`s decision comes amid concerns over...
June 30, 2026 - 22:44
Politics: High Cost Of Healthcare And The Political FalloutAmericans are feeling the squeeze of rising healthcare expenses like never before. For the first time in five years, fewer than half of U.S. adults say they can consistently afford medical care,...
June 30, 2026 - 15:13
Top GLP-1 prescription indications include sleep apnea, depression and kidney disease, study findsA new analysis of insurance claims data reveals that prescriptions for GLP-1 medications are increasingly being approved for conditions far beyond their original use for diabetes and weight loss....